Stay updated with breaking news from Pharma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Full data set supports long-term use of Veltassa® (patiromer) to control potassium buildup (hyperkalemia) in heart failure patients while on guideline-recommended RAASi therapyVeltassa® prevented the recurrence of hyperkalemia events, potentially leading to better patient outcomesST. GALLEN, Switzerland--(BUSINESS W...
BASEL, Switzerland, March 31, 2022 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today announced that its subsidiary Luye Pharma Switzerland AG has entered into agreements with Exeltis Pharma
Investegate announcements from Acacia Pharma Group plc, Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today announced the definitive notice of the end result of its public tender offer to acquire all publicly held shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348) for USD 179.25 ...
Press release content from Business Wire. The AP news staff was not involved in its creation.